Literature DB >> 6812474

Membranous glomerulonephritis as a complication of oral gold therapy.

J J Plaza, G Herrero, A Barat, J J Loutaif, L Hernando, P Vallado, H Oliva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6812474     DOI： 10.7326/0003-4819-97-4-563

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Gold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.

Authors:  A P Wilson; P J Prouse; J M Gumpel
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

Review 2.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 3.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

4.  Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study.

Authors:  O Garcia-Morteo; M E Suarez-Almazor; J A Maldonado-Cocco; R Cuttica; S Abate
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.